KANG Yujiao,ZHANG Tailei,MA Yiting,et al.An SEICR hepatitis C model with relapse and latent infection[J].Acta Scientiarum Naturalium Universitatis Sunyatseni,2023,62(03):149-160.
KANG Yujiao,ZHANG Tailei,MA Yiting,et al.An SEICR hepatitis C model with relapse and latent infection[J].Acta Scientiarum Naturalium Universitatis Sunyatseni,2023,62(03):149-160. DOI: 10.13471/j.cnki.acta.snus.2022A008.
An SEICR hepatitis C model with relapse and latent infection
According to the transmission mechanism of hepatitis C, we establish an SEICR hepatitis C model with infectious latency and relapse effect, and give the basic reproductive number of the model. It is proved that the disease-free equilibrium is globally asymptotically stable when
. Choosing the case data of hepatitis C patients of Shaanxi Province, we use the model to simulate the epidemic trend of hepatitis C in the next a few years. Finally, the sensitivity analysis of parameters shows that the number of hepatitis C cases will continue to increase in recent years. Improving public awareness of hepatitis C detection and strengthening immunity can improve the recovery rate of hepatitis C patients and reduce the proportion of disease relapse, so as to control the further spread of hepatitis C.
CHEN S L, MORGAN T R, 2006. The natural history of hepatitis C virus (HCV) infection[J]. Int J Med Sci, 3(2): 47-52.
CUI J A, ZHAO S, GUO S, et al, 2020. Global dynamics of an epidemiological model with acute and chronic HCV infections[J]. Appl Math Lett, 103: 106203.
ELBASHA E H, 2013. Model for hepatitis C virus transmissions[J]. Math Biosci Eng, 10(4): 1045-1065.
KITAGAWA K, KUNIYA T, NAKAOKA S, et al, 2019. Mathematical analysis of a transformed ODE from a PDE multiscale model of hepatitis C virus infection[J]. Bull Math Biol, 81(5): 1427-1441.
LASALLE J P, 1976. The stability of dynamical systems[M]. Philadelphia: SIAM.
MURAKAMI C, HINO K, KORENAGA M, et al, 1999. Factors predicting progression to cirrhosis and hepatocellular carcinoma in patients with transfusion-associated hepatitis C virus infection[J]. J Clin Gastroenterol, 28(2): 148-152.
RAO H Y, DUAN Z P, WANG G Q, et al, 2020. Highlights of the guidelines of prevention and treatment for hepatitis C (2019 version)[J]. Zhonghua Gan Zang Bing Za Zhi, 28(2): 129-132.
STOCKS T, MARTIN L J, KÜHLMANN-BERENZON S, et al, 2020. Dynamic modeling of hepatitis C transmission among people who inject drugs[J]. Epidemics, 30: 100378.
van den DRIESSCHE P, WATMOUGH J, 2002. Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission[J]. Math Biosci, 180(1/2): 29-48.
YUAN J, YANG Z, 2008. Global dynamics of an SEI model with acute and chronic stages[J]. J Comput Appl Math, 213(2): 465-476.
ZEILER I, LANGLANDS T, MURRAY J M, et al, 2010. Optimal targeting of hepatitis C virus treatment among injecting drug users to those not enrolled in methadone maintenance programs[J]. Drug Alcohol Dependence, 110(3): 228-233.
ZHANG S, ZHOU Y, 2012. Dynamics and application of an epidemiological model for hepatitis C[J]. Math Comput Modelling, 56(1/2): 36-42.